Technology ID
TAB-3716
Development of an Antibody, VA-17, that Detects All Forms of Oxytocin in Radioimmunoassay (RIA)
E-Numbers
E-489-2013-0
Lead Inventor
Gainer, Harold (Estate of) (National Institute of Neurological Disorders and Stroke)
Applications
Research Materials
Therapeutic Areas
Immunology
Research Products
Antibodies
Lead IC
NINDS
This technology includes the development and use of the VA-17 antibody that detects both amidated and extended forms of Oxytocin in radioimmunoassay. This antibody can be used for in vitro work, including RIA assays, to detect both forms of Oxytocin: amidated and extended.
Commercial Applications
There are no other commercially-available antibodies with this specificity to label both amidated and extended forms of Oxytocin.
Competitive Advantages
The antibody described in this technology can be used in an RIA assay to measure both amidated and extended forms of Oxytocin.
Licensing Contact: